Operating Profit Zmiana Data
Acadia Pharmaceuticals USD 34.94M 92.72M 2023-12
ALKERMES USD 43.85M 195.34M 2023-09
BioCryst Pharmaceuticals USD -11921000 37.8M 2023-09
Biogen USD 358.9M 200.1M 2023-12
Bristol-Myers Squibb USD 1.85B 473M 2023-12
Cytokinetics USD -127418000 5.15M 2023-12
Esperion Therapeutics USD -27533000 9.52M 2023-09
Gilead Sciences USD 1.61B 1.01B 2023-12
Halozyme Therapeutics USD 101.04M 12.76M 2023-12
Intra Cellular Therapies USD -34097000 4.38M 2023-12
J&J USD 4.83B 391M 2023-12
Marinus Pharmaceuticals USD -31646000 207K 2023-09
Minerva Neurosciences USD -6079000 1.56M 2023-09
Nektar Therapeutics USD -44864000 5.74M 2023-09
Neurocrine Biosciences USD 141.2M 67.6M 2023-09
RedHill Biopharma USD -4408000 33.49M 2023-06
Supernus Pharmaceuticals USD -996000 9.13M 2023-12
United Therapeutics USD 260.1M 66.9M 2023-12
Vanda Pharmaceuticals USD -2867000 4.87M 2023-06



Intra Cellular Therapies Zysk Z Działalności Operacyjnej - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2024.